Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to evaluate the correlations between active calcification and vulnerable plaque.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 13, 2012
CompletedFirst Posted
Study publicly available on registry
August 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedJuly 28, 2014
July 1, 2014
9 months
August 13, 2012
July 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Standardized 18F-NaF uptake value within the culprit plaque
At the time of diagnosis
Secondary Outcomes (4)
The relationship between 18F-NaF uptake value and calcium scores by Multidetector Computed Tomography
at the time of diagnosis
The relationship between 18F-NaF uptake value and plaque types by Multidetector Computed Tomography
at the time of diagnosis
The relationship between 18F-NaF uptake value and biomarkers
at the time of diagnosis
The relationship between 18F-NaF uptake value and invasive imagings
at the time of diagnosis
Study Arms (1)
stable angina pectoris or acute coronary syndrome
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Age more than 20
- Acute coronary syndrome or stable angina
You may not qualify if:
- Contraindications to the use of heparin, aspirin, clopidogrel, stainless metal, contrast media
- Acute ST segment elevation myocardial infarction within 12hours, heart failure, cardiac shock
- Any serious medical comorbidity such that the subject's life expectancy is less than 24 months
- Ejection fraction less than 30
- Serum creatinine level of 1.5mg/dl and over
- Vasculitis
- Unwillingness or inability to cooperate or to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asan Medical Center
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheol Whan Lee, MD, PhD
Asan Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
August 13, 2012
First Posted
August 15, 2012
Study Start
August 1, 2012
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
July 28, 2014
Record last verified: 2014-07